Bellicum Pharmaceuticals
Utility Patents
Last updated:
List of all Bellicum Pharmaceuticals patents 4 in total
| Status | Patent |
|---|---|
Grant | Utility: Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides Filling date: 8 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Methods for inducing partial apoptosis using caspase polypeptides Filling date: 8 Sep 2025 Issue date: 7 Jan 2020 |
Showing 1 to 4 of 4 patents.